Evommune goes public in New York despite US shutdown Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T W Th Fri 7 November, 2025

Bring your rare disease drug to the Japanese market — join PMDA officials to map the path forward. Find out how — get your spot.

presented by De­sign­ing for scal­a­bil­i­ty from day one: iRe­gene's foun­da­tion­al tech un­locks com­mer­cial cell ther­a­pies

news Patient in Intellia CRISPR trial dies after being hospitalized with liver injury Eccogene targets $150M in HKEX listing for MASH, obesity drugs Evommune CEO talks about sticking with $150M IPO plan during government shutdown Eledon plots path forward for kidney transplant drug despite Phase 2 miss Zuckerberg-backed Biohub hires EvolutionaryScale team in apparent end of AI startup Exclusive: Onchilles raises $25M to take cancer-killing enzyme into human trials Peer Review Novo Nordisk, Pfizer make personnel waves as they squabble over Metsera

Nov 12 2:30pm ET From JP Morgan to the next wave: What's driving biotech in 2026 sponsored by Precision AQ Nov 13 11:00am ET Driving down the cost: Optimising CGT with the right CDMO partner sponsored by OXB Dec 02 1:00pm ET Navigating JPM 2026: Biotech/biopharma trends, policy impacts & a forward look into the year sponsored by Real Chemistry Dec 03 10:30am ET AI & multi-omics for translational research sponsored by Precision for Medicine Dec 09 11:00am ET Strategic solutions for cost, time and quality challenges in drug development sponsored by Cambrex Dec 16 11:30am ET Maintaining EU GMP Annex I expectations while adopting new standards for prefilled syringe systems sponsored by Grand River

Start your year where biopharma sets its agenda. Join Endpoints News and industry leaders in San Francisco as we unpack the forces shaping dealmaking, China's emerging role and regulatory shifts. Save $200 with Early Bird rates — reserve your spot today.

endpoints pharma Updated: Trump lands sweeping cost cuts on Lilly, Novo weight loss drugs in exchange for Medicare coverage Makary pushes bounds of FDA commissioner role on prices, drug reviews and personnel FDA unveils second batch of commissioner voucher winners, including Lilly's GLP-1 pill FDA approves J&J’s Darzalex for smoldering multiple myeloma Eisai plots label expansion for subcutaneous Leqembi, details early launch progress

in case you missed it 1.